Please login to the form below
Sun
This page shows the latest Sun news and features for those working in and with pharma, biotech and healthcare.
Almirall launches Actinic Keratosis Global Day during Skin Cancer Awareness Month
Actinic keratosis (AK) is a skin lesion found on areas of the body that are usually exposed to the sun, including the extremities and in the head and neck region. ... outdoors, so there is a lot of chronic exposure to the sun.
Latest news
-
Galderma launches Rosacea Space to raise awareness
Some triggers can include sun/UV-exposure, spicy foods, alcohol, emotional stress, hot baths and beverages.
-
AstraZeneca invests in RNA tech platform
After decades of research and many frustrating setbacks, RNA technology is finally having its moment in the sun as Pfizer and Moderna COVID-19 vaccines spread immunity across the globe.
-
Q&A: Kate Callan
What gets you out of bed in the morning? My four-year-old is notorious for climbing into bed for morning snuggles as soon as the sun rises.
-
Novartis donates malaria drug for COVID-19 clinical trials
According to Sun Yanrong, the deputy head of the China National Center for Biotechnology Development under the Ministry of Science and Technology, the drug also caused patients to recover from the
-
AbbVie lauds head-to-head win for Skyrizi versus Cosentyx
Sun Pharmaceutical’s Ilumya (tildrakizumab) in recent years.
More from news
Approximately 9 fully matching, plus 122 partially matching documents found.
Latest Intelligence
-
What Hemingway got right about patient communications
By Andrew Beardshall and Matt Hunt. In Ernest Hemingway’s novel, The Sun Also Rises, a character named Mike is asked how he went bankrupt.
-
War games: why brand teams need a cunning plan that cannot fail
It’s food for thought. The ancient Chinese general Sun Tzu once famously said: “Strategy without tactics is the slowest route to victory.
-
Case study: See Below
Then, rising through a swimming pool, a place where flare-ups are commonly triggered by the sun.
-
Evolve and thrive vs wait and wither
What is the future of your marketing function? Time to fix the roof while the sun is shining.
-
Not dying of ignorance - 30 years on
Behavioural changes with HIV and AIDS. The sun shone every day in the 1980s.
More from intelligence
Approximately 0 fully matching, plus 24 partially matching documents found.
Latest appointments
-
ParagonRx appoints ex-FDA medical officer
Dr Stephen Sun joins consultancy as chief medical officer. Burlington, Massachusetts-based risk-benefit consultancy ParagonRx has appointed Dr Stephen Sun as its new chief medical officer. ... After gaining OTC experience at Reckitt-Benckiser, Dr Sun Sun
-
Health editor at The Sun newspaper joins Ruder Finn
Emma Morton appointed media strategist at PR firm. Emma Morton, health and science editor at UK newspaper The Sun, is to join the London healthcare team of communications firm Ruder Fin ... Morton spent 13 years at The Sun, initially joining as a
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Viseven opens a new center of excellence in India
Viseven Digital Content Factory key strength is their ability to run a “follow the sun” approach.
-
The desire for connected customer experiences unites stakeholders
heart rate, blood oxygen level, sleep quality, even fertility, and sun exposure.
-
Great creative is effective creative. And effective creative is affective creative
Melanoma haunts outdoor, in-the-sun Australians. It’s the most lethal cancer for those between 15 and 30. ... An application searched popular sun-related hashtags and geolocations for posts from young Australians in the sun.
-
If our patients are diverse, why are clinical trials so white?
About 71% of US adults use some form of sun protection when outdoors on a warm, sunny day – an increase of 3% from 2008.
-
3 Monkeys Zeno walks for mental health
Luckily, we had the sun shining down on us. None of us knew what to expect - indeed some of us had never been to South London or heard of Teddington!
More from PMHub
Approximately 1 fully matching, plus 20 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Europe’s cancer community publishes new report on transforming patient care
- Eli Lilly announces $450m investment in US manufacturing site
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- ASH 2022: bad blood but big advances
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- MIT researchers develop AI model to detect future lung cancer risk
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Kite and Arcellx close multiple myeloma collaboration agreement
- The challenges of identifying rare diseases
- Live Webinar: Streamlining Healthcare Delivery Through Digital Care Journeys
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- Boehringer reports positive phase 2 data for spesolimab in generalised pustular psoriasis
- EU outlines measures to mitigate antibiotic shortage across Europe
- The challenges of identifying rare diseases
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- This month in 1917: A tale of two Mercks
Latest intelligence
- The challenges of identifying rare diseases
- With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
- 5 ways we’re enhancing our services to support our clients in 2023
- Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
- ASH 2022: bad blood but big advances
- Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
